NEW! Automated Tissue Dissociation Systems
S2 Genomics and their exclusive distributor for Germany and Austria, Dunn Labortechnik, present the new Singulator™ Syst…
S2 Genomics and their exclusive distributor for Germany and Austria, Dunn Labortechnik, present the new Singulator™ Syst…
Two of six patients receiving NOX-A12 in combination with bevacizumab and radiotherapy exceeded 24-month survival si…
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius, with an intravenous an…
Resminostat (Kinselby) as a maintenance therapy is now clinically proven to postpone disease progression in advanced Cut…
The US trade magazine "Healthcare Tech Outlook" recently named ibidi GmbH one of the ten best European manufacturers of…
Fast Track designation awarded by the FDA serves as an external validation of the potential of NOX-A12 for unmet need in…
479,624 Warrants Z were exercised resulting in the issuance of 599,530 new ordinary shares Outstanding 3,326,104 War…
ProteinQure, the leading startup in the computational design of peptide drugs, announces a significant breakthrough in t…
Interim clinical data update on ACTengine® IMA203 GEN1 (PRAME) in melanoma at RP2D in November 2023: 50% confirmed objec…
Clinical trial protocol approved in the US to initiate Phase 2 study with NOX-A12 in glioblastoma providing a clear road…